Department of Animal Clinical Science, Karaj Branch, Islamic Azad University, Karaj, Iran.
Theriogenology. 2011 Dec;76(9):1723-9. doi: 10.1016/j.theriogenology.2011.07.004. Epub 2011 Aug 27.
The objective of this study was to evaluate the effects of early postpartum PGF two alpha treatment on reproductive performance in dairy cows with calving and puerperal traits. A total of 363 Holstein cows (128 primiparous and 235 multiparous) were selected based on the presence of at least one of calving and puerperal traits (dystocia, retained placenta, twin, abortion, and postpartum uterine infections) and were assigned to two groups (treatment and control) irrespective of presence or absence of luteal tissue. Cows in the treatment group were treated twice with 25 mg dinoprost 8 h apart on day 20 postpartum, and for the control group saline placebo was administered. As it was speculated that the timing of a second dose would mimic the release of endogenous PGF2α from the uterus, our hypothesis was that two doses of PGF2α 8 h apart may increase the duration of elevated plasma prostaglandin F2α metabolite concentration in these cows. Recorded reproductive variables included days to first estrus, days to first AI, first service conception rate, pregnancy by 150 days in milk, service per conception, open days, and the percentage of repeat breeder animals. The data were analyzed using SPSS (Version 15) (IBM North America, New York, NY, USA) and Minitab (Version 14) (Minitab, State College, PA, USA). Although early postpartum PGF2α treatment had no effect on days to first estrus (36.7 days vs. 34.9 days, P = 0.056) and days to first AI (70.5 days vs. 72.2 days, P = 0.537), it increased first service conception rate (47.1% vs. 27.6%, P < 0.001); and this was more remarkable in primiparous cows (64.7% vs. 25%, P < 0.001). PGF2α treatment reduced the mean service per conception (1.92 vs. 2.72, P < 0.001) and the mean open days (112 days vs. 144 days, P < 0.001), and increased pregnancy by 150 days in milk (DIM) (80% vs. 66%, P = 0.004). The prevalence of repeat breeder syndrome in cows with calving and puerperal traits was reduced by PGF2α treatment (10% vs. 29.8%, P < 0.001). In conclusion, treatment of cows with calving and puerperal traits twice with a luteolytic dose of PGF2α 8 h apart on Day 20 postpartum improved reproductive performance and reduced the prevalence of repeat breeder syndrome.
本研究旨在评估产后早期使用 PGF2α 治疗对具有分娩和产褥特征的奶牛繁殖性能的影响。根据至少有一种分娩和产褥特征(难产、胎衣滞留、双胎、流产和产后子宫感染)的存在,选择了 363 头荷斯坦奶牛(128 头初产和 235 头经产),并将其分为两组(治疗组和对照组),无论是否存在黄体组织。治疗组奶牛在产后第 20 天,每 8 小时用 25mg 地诺前列酮治疗 2 次,对照组则给予生理盐水安慰剂。由于我们推测第二次剂量的时机可能模拟内源性 PGF2α 从子宫中的释放,因此我们假设 8 小时间隔两次给予 PGF2α 可能会增加这些奶牛血浆前列腺素 F2α 代谢物浓度升高的持续时间。记录的繁殖变量包括首次发情天数、首次人工授精天数、首次配种受胎率、产后 150 天怀孕、每配种受胎次数、开放天数和重复配种动物的百分比。使用 SPSS(版本 15)(IBM 北美,纽约,NY,美国)和 Minitab(版本 14)(Minitab,州立学院,PA,美国)分析数据。尽管产后早期使用 PGF2α 治疗对首次发情天数(36.7 天 vs. 34.9 天,P=0.056)和首次人工授精天数(70.5 天 vs. 72.2 天,P=0.537)没有影响,但它增加了首次配种受胎率(47.1% vs. 27.6%,P<0.001);而且初产奶牛的效果更为显著(64.7% vs. 25%,P<0.001)。PGF2α 治疗降低了平均每配种受胎次数(1.92 次 vs. 2.72 次,P<0.001)和平均开放天数(112 天 vs. 144 天,P<0.001),并增加了产后 150 天怀孕率(DIM)(80% vs. 66%,P=0.004)。PGF2α 治疗降低了具有分娩和产褥特征的奶牛的重复配种综合征的患病率(10% vs. 29.8%,P<0.001)。总之,产后第 20 天,每隔 8 小时对具有分娩和产褥特征的奶牛进行两次黄体溶解剂量的 PGF2α 治疗,可改善繁殖性能并降低重复配种综合征的患病率。